Annual Total Debt
$119.46 M
-$16.57 M-12.18%
December 31, 2022
Summary
- As of February 10, 2025, RETA annual total debt is $119.46 million, with the most recent change of -$16.57 million (-12.18%) on December 31, 2022.
- During the last 3 years, RETA annual total debt has fallen by -$35.55 million (-22.93%).
Performance
RETA Total Debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Quarterly Total Debt
$166.00 M
+$48.07 M+40.76%
June 30, 2023
Summary
- As of February 10, 2025, RETA quarterly total debt is $166.00 million, with the most recent change of +$48.07 million (+40.76%) on June 30, 2023.
- Over the past year, RETA quarterly total debt has increased by +$23.49 million (+16.48%).
Performance
RETA Quarterly Total Debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Total Debt Formula
Total Debt = Short Term Debt + Long Term Debt
RETA Total Debt Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
---|---|---|
1 y1 year | -12.2% | +16.5% |
3 y3 years | -22.9% | +100.0% |
5 y5 years | +509.1% | +111.2% |
RETA Total Debt Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
---|---|---|---|---|---|
3 y | 3-year | -12.2% | at low | at high | -29.0% |
5 y | 5-year | -22.9% | -95.5% | at high | -100.0% |
alltime | all time | -22.9% | -100.0% | at high | -100.0% |
Reata Pharmaceuticals Total Debt History
Date | Annual | Quarterly |
---|---|---|
Jun 2023 | - | $166.00 M(+40.8%) |
Mar 2023 | - | $117.93 M(-1.3%) |
Dec 2022 | $119.46 M(-12.2%) | $119.46 M(-15.1%) |
Sep 2022 | - | $140.71 M(-1.3%) |
Jun 2022 | - | $142.51 M(+0.7%) |
Mar 2022 | - | $141.59 M(+4.1%) |
Dec 2021 | $136.03 M(+2455.6%) | $136.03 M(>+9900.0%) |
Sep 2021 | - | $0.00(0.0%) |
Jun 2021 | - | $0.00(0.0%) |
Mar 2021 | - | $0.00(-100.0%) |
Dec 2020 | $5.32 M(-96.6%) | $5.32 M(>+9900.0%) |
Sep 2020 | - | $0.00(0.0%) |
Jun 2020 | - | $0.00(-100.0%) |
Mar 2020 | - | $155.51 M(+0.3%) |
Dec 2019 | $155.02 M(+95.7%) | $155.02 M(+93.2%) |
Sep 2019 | - | $80.24 M(+0.4%) |
Jun 2019 | - | $79.90 M(+0.4%) |
Mar 2019 | - | $79.56 M(+0.4%) |
Date | Annual | Quarterly |
---|---|---|
Dec 2018 | $79.22 M(+303.9%) | $79.22 M(+0.4%) |
Sep 2018 | - | $78.88 M(+0.4%) |
Jun 2018 | - | $78.59 M(+299.5%) |
Mar 2018 | - | $19.67 M(+0.3%) |
Dec 2017 | $19.61 M(>+9900.0%) | $19.61 M(-1.1%) |
Sep 2017 | - | $19.83 M(+0.2%) |
Jun 2017 | - | $19.79 M(+0.2%) |
Mar 2017 | - | $19.75 M(>+9900.0%) |
Dec 2016 | $0.00(0.0%) | $0.00(0.0%) |
Sep 2016 | - | $0.00(0.0%) |
Jun 2016 | - | $0.00(0.0%) |
Mar 2016 | - | $0.00(0.0%) |
Dec 2015 | $0.00(0.0%) | $0.00(0.0%) |
Sep 2015 | - | $0.00(0.0%) |
Jun 2015 | - | $0.00(0.0%) |
Mar 2015 | - | $0.00(0.0%) |
Dec 2014 | $0.00(0.0%) | $0.00 |
Dec 2013 | $0.00 | - |
FAQ
- What is Reata Pharmaceuticals annual total debt?
- What is the all time high annual total debt for Reata Pharmaceuticals?
- What is Reata Pharmaceuticals annual total debt year-on-year change?
- What is Reata Pharmaceuticals quarterly total debt?
- What is the all time high quarterly total debt for Reata Pharmaceuticals?
- What is Reata Pharmaceuticals quarterly total debt year-on-year change?
What is Reata Pharmaceuticals annual total debt?
The current annual total debt of RETA is $119.46 M
What is the all time high annual total debt for Reata Pharmaceuticals?
Reata Pharmaceuticals all-time high annual total debt is $155.02 M
What is Reata Pharmaceuticals annual total debt year-on-year change?
Over the past year, RETA annual total debt has changed by -$16.57 M (-12.18%)
What is Reata Pharmaceuticals quarterly total debt?
The current quarterly total debt of RETA is $166.00 M
What is the all time high quarterly total debt for Reata Pharmaceuticals?
Reata Pharmaceuticals all-time high quarterly total debt is $166.00 M
What is Reata Pharmaceuticals quarterly total debt year-on-year change?
Over the past year, RETA quarterly total debt has changed by +$23.49 M (+16.48%)